Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · IEX Real-Time Price · USD
21.48
-2.18 (-9.21%)
At close: Jul 2, 2024, 4:00 PM
21.01
-0.47 (-2.19%)
After-hours: Jul 2, 2024, 6:58 PM EDT
ARCT Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ARCT stock have an average target of 62.83, with a low estimate of 48 and a high estimate of 86. The average target predicts an increase of 192.50% from the current stock price of 21.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ARCT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +179.33% | Jul 2, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $87 → $86 | Strong Buy | Maintains | $87 → $86 | +300.37% | May 10, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $81 → $87 | Strong Buy | Maintains | $81 → $87 | +305.03% | Mar 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +179.33% | Mar 8, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $45 → $58 | Buy | Maintains | $45 → $58 | +170.02% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
185.47M
from 166.80M
Increased by 11.19%
Revenue Next Year
216.74M
from 185.47M
Increased by 16.86%
EPS This Year
-3.09
from -1.12
EPS Next Year
-1.15
from -3.09
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 239.4M | 407.4M | 937.9M | 1.4B | 2.0B |
Avg | 185.5M | 216.7M | 436.4M | 567.8M | 1.0B |
Low | 135.7M | 93.1M | 142.0M | 228.2M | 324.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 43.5% | 119.7% | 332.7% | 231.8% | 260.7% |
Avg | 11.2% | 16.9% | 101.3% | 30.1% | 83.0% |
Low | -18.6% | -49.8% | -34.5% | -47.7% | -42.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.88 | 3.83 | 11.53 | 20.44 | 31.03 |
Avg | -3.09 | -1.15 | 2.65 | 5.01 | 14.52 |
Low | -5.17 | -6.79 | -6.45 | -4.55 | 2.65 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 672.4% | 519.5% |
Avg | - | - | - | 89.2% | 190.0% |
Low | - | - | - | - | -47.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.